BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
M. Milovancev, D. S. Russell. Surgical margins in the veterinary cancer patientVeterinary and Comparative Oncology 2017; 15(4): 1136 doi: 10.1111/vco.12284
2
Swathi Mohankumar, Tushar Patel. Extracellular vesicle long noncoding RNA as potential biomarkers of liver cancerBriefings in Functional Genomics 2016; 15(3): 249 doi: 10.1093/bfgp/elv058
3
Zhizhou Huang, Xueqiong Zhou, Yangfan He, Xiangyu Ke, Ying Wen, Fei Zou, Xuemei Chen. Hyperthermia enhances 17-DMAG efficacy in hepatocellular carcinoma cells with aggravated DNA damage and impaired G2/M transitionScientific Reports 2016; 6(1) doi: 10.1038/srep38072
4
Malkhaz Mizandari, Natela Paksashvili, Nino Kikodze, Tamta Azrumelashvili, Ia Pantsulaia, Koba Shanava, Nona Janikashvili, Tinatin Chikovani. Long-term survival in a patient with low-level inflammatory markers and liver metastasis, converted resectable by TACEImmunotherapy 2017; 9(13): 1067 doi: 10.2217/imt-2017-0069
5
Wan-Joon Kim, Tae-Wan Lim, Pyoung-Jae Park, Sae-Byeol Choi, Wan-Bae Kim. Prognostic markers affecting the early recurrence of hepatocellular carcinoma with liver cirrhosis after curative resectionThe International Journal of Biological Markers 2019; 34(2): 123 doi: 10.1177/1724600819834306
6
Matteo Canale, Paola Ulivi, Francesco Giuseppe Foschi, Emanuela Scarpi, Serena De Matteis, Gabriele Donati, Giorgio Ercolani, Mario Scartozzi, Luca Faloppi, Alessandro Passardi, Emiliano Tamburini, Martina Valgiusti, Giorgia Marisi, Giovanni Luca Frassineti, Andrea Casadei Gardini. Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinomaCritical Reviews in Oncology/Hematology 2018; 129: 44 doi: 10.1016/j.critrevonc.2018.06.017